Frontiers in Microbiology,
Journal Year:
2017,
Volume and Issue:
8
Published: Sept. 26, 2017
Accumulating
evidence
indicates
that
gut
microbiota
participates
in
the
pathogenesis
and
progression
of
liver
diseases.
The
severity
immune-mediated
injury
is
associated
with
different
microbial
communities.
Akkermansia
muciniphila
can
regulate
immunologic
metabolic
functions.
However,
little
known
about
its
effects
on
structure
function.
This
study
investigated
effect
A.
potential
underlying
mechanisms.
Twenty-two
C57BL/6
mice
were
assigned
to
three
groups
(N
=
7-8
per
group)
continuously
administrated
MucT
or
PBS
by
oral
gavage
for
14
days.
Mouse
feces
collected
analysis
15th
day,
acute
was
induced
Concanavalin
A
(Con
A,
15
mg/kg)
injection
through
tail
vein.
Samples
(blood,
liver,
ileum,
colon)
assessed
injury,
systemic
inflammation,
intestinal
barrier
We
found
administration
decreased
serum
ALT
AST
alleviated
histopathological
damage
Con
Serum
levels
pro-inflammatory
cytokines
chemokines
(IL-2,
IFN-γ,
IL-12p40,
MCP-1,
MIP-1a,
MIP-1b)
substantially
attenuated.
significantly
hepatocellular
apoptosis;
Bcl-2
expression
increased,
but
Fas
DR5
decreased.
Further
investigation
showed
enhanced
Occludin
Tjp-1
inhibited
CB1
receptor,
which
strengthened
barriers
reduced
LPS
level.
Fecal
16S
rRNA
sequence
indicated
increased
richness
diversity.
community
Akk
group
clustered
distinctly
from
pretreated
PBS.
Relative
abundance
Firmicutes
Bacteroidetes
Correlation
injury-related
factors
(IL-12p40,
DR5)
negatively
specific
genera
(Ruminococcaceae_UCG_009,
Lachnospiraceae_UCG_001,
Akkermansia),
enriched
muciniphila.
Our
results
suggested
had
beneficial
alleviating
inflammation
death.
These
may
be
driven
protective
profile
bacteria.
provide
a
new
perspective
immune
function
host
Microbiology and Molecular Biology Reviews,
Journal Year:
2017,
Volume and Issue:
81(4)
Published: Nov. 8, 2017
SUMMARY
The
human
gut
microbiota
is
engaged
in
multiple
interactions
affecting
host
health
during
the
host's
entire
life
span.
Microbes
colonize
neonatal
immediately
following
birth.
establishment
and
interactive
development
of
this
early
are
believed
to
be
(at
least
partially)
driven
modulated
by
specific
compounds
present
milk.
It
has
been
shown
that
certain
genomes
infant
commensals,
particular
those
bifidobacterial
species,
genetically
adapted
utilize
glycans
secretory
fluid,
thus
representing
a
very
intriguing
example
host-microbe
coevolution,
where
both
partners
benefit.
In
recent
years,
various
metagenomic
studies
have
tried
dissect
composition
functionality
microbiome
explore
distribution
across
different
ecological
niches
biogeography
corresponding
microbial
consortia,
including
bacteria
viruses,
healthy
ill
subjects.
Such
analyses
linked
features
microbiota/microbiome,
such
as
reduced
diversity
or
aberrant
composition,
intestinal
illnesses
infants
disease
states
manifested
at
later
stages
life,
asthma,
inflammatory
bowel
disease,
metabolic
disorders.
Thus,
growing
number
reported
on
how
composition/development
may
affect
risk
factors
related
adult
conditions.
This
concept
fueled
strategies
shape
based
functional
food
products.
review,
we
describe
microbiota,
mechanisms
drive
its
consortia
molded
natural
artificial
interventions.
Finally,
discuss
relevance
key
players
bifidobacteria,
with
respect
their
role
disease.
Gut,
Journal Year:
2022,
Volume and Issue:
71(5), P. 1020 - 1032
Published: Feb. 1, 2022
The
gut
microbiota
is
now
considered
as
one
of
the
key
elements
contributing
to
regulation
host
health.
Virtually
all
our
body
sites
are
colonised
by
microbes
suggesting
different
types
crosstalk
with
organs.
Because
development
molecular
tools
and
techniques
(ie,
metagenomic,
metabolomic,
lipidomic,
metatranscriptomic),
complex
interactions
occurring
between
microorganisms
progressively
being
deciphered.
Nowadays,
deviations
linked
many
diseases
including
obesity,
type
2
diabetes,
hepatic
steatosis,
intestinal
bowel
(IBDs)
several
cancer.
Thus,
that
various
pathways
involved
in
immunity,
energy,
lipid
glucose
metabolism
affected.
In
this
review,
specific
attention
given
provide
a
critical
evaluation
current
understanding
field.
Numerous
mechanisms
explaining
how
bacteria
might
be
causally
protection
or
onset
discussed.
We
examine
well-established
metabolites
short-chain
fatty
acids,
bile
trimethylamine
N-oxide)
extend
more
recently
identified
actors
endocannabinoids,
bioactive
lipids,
phenolic-derived
compounds,
advanced
glycation
end
products
enterosynes)
their
receptors
such
peroxisome
proliferator-activated
receptor
alpha
(PPARα)
gamma
(PPARγ),
aryl
hydrocarbon
(AhR),
G
protein-coupled
GPR41,
GPR43,
GPR119,
Takeda
5).
Altogether,
complexity
aspects
linking
health
will
help
set
basis
for
novel
therapies
already
developed.
Gut,
Journal Year:
2018,
Volume and Issue:
67(9), P. 1716 - 1725
Published: June 22, 2018
The
microbiome
has
received
increasing
attention
over
the
last
15
years.
Although
gut
microbes
have
been
explored
for
several
decades,
investigations
of
role
microorganisms
that
reside
in
human
attracted
much
beyond
classical
infectious
diseases.
For
example,
numerous
studies
reported
changes
microbiota
during
not
only
obesity,
diabetes,
and
liver
diseases
but
also
cancer
even
neurodegenerative
is
viewed
as
a
potential
source
novel
therapeutics.
Between
2013
2017,
number
publications
focusing
on
was,
remarkably,
12
900,
which
represents
four-fifths
total
40
years
investigated
this
topic.
This
review
discusses
recent
evidence
impact
metabolic
disorders
focus
selected
key
mechanisms.
aims
to
provide
critical
analysis
current
knowledge
field,
identify
putative
issues
or
problems
discuss
misinterpretations.
abundance
metagenomic
data
generated
comparing
diseased
healthy
subjects
can
lead
erroneous
claim
bacterium
causally
linked
with
protection
onset
disease.
In
fact,
environmental
factors
such
dietary
habits,
drug
treatments,
intestinal
motility
stool
frequency
consistency
are
all
influence
composition
should
be
considered.
cases
bacteria
Prevotella
copri
Akkermansia
muciniphila
will
discussed
examples.
Frontiers in Microbiology,
Journal Year:
2017,
Volume and Issue:
8
Published: Sept. 22, 2017
Metabolic
disorders
associated
with
obesity
and
cardiometabolic
are
worldwide
epidemic.
Among
the
different
environmental
factors,
gut
microbiota
is
now
considered
as
a
key
player
interfering
energy
metabolism
host
susceptibility
to
several
non-communicable
diseases.
next-
generation
beneficial
microbes
that
have
been
identified,
Akkermansia
muciniphila
promising
candidate.
Indeed,
A.
inversely
obesity,
diabetes,
diseases
low-grade
inflammation.
Besides
numerous
correlations
observed,
large
body
of
evidence
has
demonstrated
causal
impact
this
bacterium
in
variety
preclinical
models.
Translating
these
exciting
observations
human
would
be
next
logic
step
it
appears
obstacles
prevent
use
A.muciniphila
administration
humans
overcome.
Moreover,
lines
indicate
pasteurization
not
only
increases
its
stability
but
more
importantly
efficacy.
This
strongly
positions
forefront
candidates
for
developing
novel
food
or
pharma
supplements
effects.
Finally,
specific
protein
present
on
outer
membrane
muciniphila,
termed
Amuc_1100,
could
strong
candidate
future
drug
development.
In
conclusion,
plants
related
knowledge,
known
pharmacognosy,
source
designing
drugs
over
last
century,
we
propose
microbiomegnosy,
knowledge
our
microbiome,
can
become
therapies.
The Journal of Experimental Medicine,
Journal Year:
2018,
Volume and Issue:
216(1), P. 20 - 40
Published: Oct. 15, 2018
Over
the
past
decade,
our
view
of
human-associated
microbes
has
expanded
beyond
that
a
few
species
toward
an
appreciation
diverse
and
niche-specialized
microbial
communities
develop
in
human
host
with
chronological
age.
The
largest
reservoir
exists
distal
gastrointestinal
tract,
both
lumen,
where
facilitate
primary
secondary
metabolism,
on
mucosal
surfaces,
they
interact
immune
cell
populations.
While
local
microbial-driven
immunomodulation
gut
is
well
described,
more
recent
studies
have
demonstrated
role
for
microbiome
influencing
remote
organs
hematopoietic
function.
Unsurprisingly,
therefore,
perturbation
to
composition
function
microbiota
been
associated
chronic
diseases
ranging
from
inflammatory
metabolic
conditions
neurological,
cardiovascular,
respiratory
illnesses.
Considerable
effort
currently
focused
understanding
natural
history
development
humans
context
health
outcomes,
parallel
improving
knowledge
microbiome-host
molecular
interactions.
These
efforts
ultimately
aim
effective
approaches
rehabilitate
perturbed
ecosystems
as
means
restore
or
prevent
disease.
This
review
details
modulating
focus
discusses
strategies
manipulating
management
prevention
conditions.
Microbial Biotechnology,
Journal Year:
2019,
Volume and Issue:
12(6), P. 1109 - 1125
Published: April 21, 2019
Summary
Akkermansia
muciniphila
(
A.
),
an
intestinal
symbiont
colonizing
in
the
mucosal
layer,
is
considered
to
be
a
promising
candidate
as
probiotics.
known
have
important
value
improving
host
metabolic
functions
and
immune
responses.
Moreover,
may
modifying
cancer
treatment.
However,
most
of
current
researches
focus
on
correlation
between
diseases,
little
about
causal
relationship
them.
Few
intervention
studies
are
limited
animal
experiments,
explored
its
safety
efficacy
humans.
Therefore,
critical
analysis
knowledge
will
play
foundation
for
it
defined
new
beneficial
microbe.
This
article
review
bacteriological
characteristics
,
well
with
disorders,
diseases
therapy.
Nutrients,
Journal Year:
2018,
Volume and Issue:
10(8), P. 988 - 988
Published: July 29, 2018
The
intestinal
microbiota,
composed
of
pro-
and
anti-inflammatory
microbes,
has
an
essential
role
in
maintaining
gut
homeostasis
functionality.
An
overly
hygienic
lifestyle,
consumption
processed
fiber-poor
foods,
or
antibiotics
are
major
factors
modulating
the
microbiota
possibly
leading
to
longstanding
dysbiosis.
Dysbiotic
is
characterized
have
altered
composition,
reduced
diversity
stability,
as
well
increased
levels
lipopolysaccharide-containing,
proinflammatory
bacteria.
Specific
commensal
species
novel
probiotics,
so-called
next-generation
could
restore
health
by
means
attenuating
inflammation
strengthening
epithelial
barrier.
In
this
review
we
summarize
latest
findings
considering
beneficial
effects
promising
commensals
across
all
phyla.
These
include
already
well-known
bifidobacteria,
which
use
extracellular
structures
secreted
substances
promote
health.
Faecalibacterium
prausnitzii,
Roseburia
intestinalis,
Eubacterium
hallii
metabolize
dietary
fibers
short-chain
fatty
acid
producers
providing
energy
sources
for
enterocytes
achieving
gut.
Akkermansia
muciniphila
exerts
action
metabolic
diseases
fortifies
barrier
function.
health-promoting
Bacteroides
relatively
recently
discovered
with
excreted
immunomodulatory
molecules.
promising,
unconventional
probiotics
be
a
part
biotherapeutic
strategies
future.
Cells,
Journal Year:
2021,
Volume and Issue:
10(11), P. 3164 - 3164
Published: Nov. 14, 2021
The
gut
microbiota
is
responsible
for
recovering
energy
from
food,
providing
hosts
with
vitamins,
and
a
barrier
function
against
exogenous
pathogens.
In
addition,
it
involved
in
maintaining
the
integrity
of
intestinal
epithelial
barrier,
crucial
functional
maturation
immune
system.
Western
diet
(WD)—an
unhealthy
high
consumption
fats—can
be
broadly
characterized
by
overeating,
frequent
snacking,
prolonged
postprandial
state.
term
WD
commonly
known
intuitively
understood.
However,
strict
digital
expression
nutrient
ratios
not
precisely
defined.
Based
on
US
data
1908–1989,
calory
intake
available
fats
increased
32%
to
45%.
Besides
metabolic
aspects
(hyperinsulinemia,
insulin
resistance,
dyslipidemia,
sympathetic
nervous
system
renin-angiotensin
overstimulation,
oxidative
stress),
consequences
excessive
fat
(high-fat
diet—HFD)
comprise
dysbiosis,
dysfunction,
permeability,
leakage
toxic
bacterial
metabolites
into
circulation.
These
can
strongly
contribute
development
low-grade
systemic
inflammation.
This
narrative
review
highlights
most
important
recent
advances
linking
HFD-driven
dysbiosis
HFD-related
inflammation,
presents
pathomechanisms
these
phenomena,
examines
possible
causative
relationship
between
pro-inflammatory
status
changes.